Morphine Sulfate NDC 68000-110

NDC codes

FDA NDC Directory

Product NDC (as listed)68000-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68000-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68000-110-01	68000011001	10 SYRINGE in 1 CARTON (68000-110-01) / .125 mL in 1 SYRINGE (68000-110-06)Marketed from May 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Morphine Sulfate
Generic name (nonproprietary): morphine sulfate
Active ingredients: Morphine sulfate — 20 mg/mL
Dosage form: Solution
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203518
Marketing start: May 1, 2026
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Full Opioid Agonists (Mechanism)
Identifiers: Product ID 68000-110_50c61ad1-c1b3-25bc-e063-6394a90a59c5SPL ID 50c61ad1-c1b3-25bc-e063-6394a90a59c5SPL set ID 5422cdac-8073-41fc-8665-ffe9797f5c02RxCUI 892625UNII X3P646A2J0
Pharmacologic class: Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468000011001 followed by a unit qualifier and the quantity

Package 68000-0110-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Morphine Sulfate Oral Solution 2 mg/mL is indicated for the management of: adults with pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. pediatric patients 2 years of age and older with pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Morphine Sulfate Oral Solution 20 mg/mL is indicated for use in opioid-tolerant adult patients who require higher doses of opioids for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. Limitations of Use: Because of the risks of addiction, abuse, misuse, overdose, and death, which can occ…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203518

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203518
Product	Strength	Form · route	Labeler	Product NDC
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	Bryant Ranch Prepack	63629-2301
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	Bryant Ranch Prepack	63629-2302
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	American Health Packaging	68000-114
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	American Health Packaging	68000-111
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	American Health Packaging	68000-112
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	American Health Packaging	68000-113
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	Cranbury Pharmaceuticals, LLC	27808-082
Morphine Sulfate	Morphine sulfate 20 mg/mL	SolutionOral	Bryant Ranch Prepack	72162-1282